Summary of Study ST000499

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000376. The data can be accessed directly via it's Project DOI: 10.21228/M8FP4B This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000499
Study TitleNAD+ in neurodegeneration
Study TypeBaseline comparison of NAD metabolism in iPSC-derived neurons
Study SummaryDifferentiated iPSCs from patients and controls and knockout cells
Institute
University of Florida
DepartmentSECIM
Last NameDeleidi
First NameMichela
AddressOtfried-Müller. Str 23, 72076, Tübingen, Germany
Emailmichela.deleidi@dzne.de
Phonenone
Submit Date2016-10-11
Num Groups3
Total Subjects17
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2017-11-20
Release Version1
Michela Deleidi Michela Deleidi
https://dx.doi.org/10.21228/M8FP4B
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:TR000534
Treatment Summary:80% confluence, 48 hrs after last media change, differentiation medium (Neurobasal/B27/L-glut containing medium supplemented with BDNF, ascorbic acid , GDNF, TGFβ3, dibutyryl cAMP and DAPT.
  logo